KRAS G12DTag: KRAS G12D

Genmab, Incyte Plan Phase 1/2 Trial for KRAS Cancer

Genmab and Incyte will test petosemtamab with INCB161734 and chemotherapy in first-line KRAS G12D metastatic colorectal cancer.

Elsy kanana · Oct 25, 06:00